New anti-obesity medication almost twice as effective as most currently approved weight-loss drugs
‘By far the most effective drug intervention we have seen for weight management’
Effective anti-obesity medication could help limit the need for surgery.
A new anti-obesity medication was shown to be almost twice as effective at helping individuals lose weight than some of the current weight-loss drugs on the market, according to a new landmark study conducted at Northwestern Medicine and other institutions.
The drug, semaglutide, taken once a week at 2.4 mg, works by suppressing appetite centers in the brain to reduce hunger and calorie intake. It could be a gamechanger for those who struggle with obesity, which impacts more than 40% of adults in the U.S. Obesity is associated with multiple complications such as type 2 diabetes, hypertension, heart disease, arthritis, sleep apnea, some forms of cancer and decreased life expectancy.
E-Mail
Credit: Penn Nursing
PHILADELPHIA (January 25, 2021) - While eating less and moving more are the basics of weight control and obesity treatment, finding ways to help people adhere to a weight-loss regimen is more complicated. Understanding what features make a diet easier or more challenging to follow can help optimize and tailor dietary approaches for obesity treatment.
A new paper from the University of Pennsylvania School of Nursing (Penn Nursing) analyzed different dietary approaches and clinical trials to better understand how to optimize adherence and subsequent weight reduction. The findings have been published in the
Journal of Clinical Investigation. There is not convincing evidence that one diet is universally easier to adhere to than another for extended periods, a feature necessary for long-term weight management, says Ariana M. Chao, PhD, CRNP, Assistant Professor of Nursing at Penn Nursing and lead investigator of the paper. Progress in improving dieta